Zinzino AB began business operations in the fall of 2007. The principal activity of the company is the ownership and development of direct marketing companies and related business activities.
In 2009, Zinzino Nordic AB was acquired partly through a directed share issue to shareholders in Zinzino Nordic AB and partly through a subscription of shares in the preferential rights issue Zinzino Nordic AB carried out in December, 2009. This gave Zinzino AB control over 97% of the votes and 92% of the equity in Zinzino Nordic AB. As of December 31, 2014, ownership had increased to 93% of equity.
Zinzino AB has been listed on the Nasdaq OMX First North as of December 11, 2014.
Share performance has been very positive, above all over the past two years.
In 2011, the Group expanded to include companies in Estonia and Lithuania. In 2012, companies were also launched in Latvia and Iceland. In 2013, a company was started in the USA, headquartered in Jupiter, Florida. Unlike the previous Group structure, the new subsidiaries are directly owned by Zinzino AB.
In 2014, companies were established in Poland and the Netherlands. In 2014, Zinzino AB acquired the remaining shares in BioActive Foods AS and 85% of the shares in Faun Pharma AS.
A company was started in Canada in 2015.